| Factor Information | |
|---|---|
| Data ID | 658 |
| Factor | NYHA decreased cardiac function class≥2 |
| Description | N/A |
| Biomarker | NA |
| Classification | A6 (clinical factor - other) |
| Association | |
|---|---|
| Application | risk assessment |
| Objective | To access the adverse outcome rate of pregnancies with PAH-CHD |
| p Value | 0.02 |
| Conclusion | The incidence of deterioration in NYHA classes(≥2) during pregnancy among three groups was statiscally significant. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 474 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | ASD/VSD/PDA/ECD/TOF/EA/DORV/VSD, ES/PDA, ES/ASD, VSD, PDA, ES/ASD, ES |
| Reference | |
|---|---|
| PMID | 29136712 |
| Year | 2017 |
| Title | Long-term outcome and prognostic factors in pregnant women with pulmonary arterial hypertension associated with congenital heart disease |
| Sample | ||
|---|---|---|
| Population | pregnant women | |
| Source | data | |
| Region | China, Beijing | |
| Method | univariate analysis | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | corrective surgery for cardiac malformations. | |
| Group | severe PAH(Treatment) | moderate PAH / mild PAH(Control) |
| Number | 22 | 6(moderate PAH), 0(mild PAH) |
| Age | 27.77±5.11 years (severe PAH) | 28.64±5.25 years(moderate PAH) 28.09±4.89 years(mild PAH) |
| Gender (Male: Female) | female | female |
| Marker Level | 0.333 | 18.2%(moderate PAH), 0% (mild PAH) |
